| Pierre Fabre Pharma SA - Selenase peroral, Trinklösung |
| 53770 | | 01 | | Selenase peroral | | Trinklösung | | A12CE02 | | Sodium Selenite | | 09.02.2001 | | |
|
| Composition |
| natrii selenis pentahydricus 166.5 µg corresp. selenium 50 µg, excipiens ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution (oral) | | | | | | Active Agent | Dose |
|---|
| Sodium Selenide Pentahydrate | 166.5 µg/ml correspond Selenium 50 µg/ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | 20 1 ampoule(s) à 2 ml | PR | PR | B | | Yes | | 037 | 90 1 ampoule(s) à 2 ml | PR | PR | B | | Yes | | 046 | 10 1 ampoule(s) à 10 ml | PR | PR | B | | Yes |
|
